Pegasys [peginterferon alfa-2a] plus entecavir versus entecavir alone for hepatitis Be antigen-positive chronic hepatitis B
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Entecavir (Primary) ; Peginterferon alfa-2a
- Indications Hepatitis B
- Focus Therapeutic Use
- 28 Apr 2013 Interim results presented at the 48th Annual Meeting of the European Association for the Study of the Liver.
- 29 Dec 2008 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 02 Feb 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History